The DOI matches its Crossref record; 641 of the 641 references it cites were found in a registry or an index.
The Treatment of Cushing's Disease
Open accessAbstract
Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe endocrine disease caused by a corticotroph pituitary tumor and associated with increased morbidity and mortality. The first-line treatment for CD is pituitary surgery, which is followed by disease remission in around 78% and relapse in around 13% of patients during the 10-year period after surgery, so that nearly one third of patients experience in the long-term a failure of surgery and require an additional second-line treatment. Patients with persistent or recurrent CD require additional treatments, including pituitary radiotherapy, adrenal surgery, and/or medical therapy. Pituitary radiotherapy is effective in controlling cortisol excess in a large percentage of patients, but it is associated with a considerable risk of hypopituitarism. Adrenal surgery is followed by a rapid and definitive control of cortisol excess in nearly all patients, but it induces adrenal insufficiency. Medical therapy has recently acquired a more important role compared to the past, due to the recent employment of novel compounds able to control cortisol secretion or action. Currently, medical therapy is used as a presurgical treatment, particularly for severe disease; or as postsurgical treatment, in cases of failure or incomplete surgical tumor resection; or as bridging therapy before, during, and after radiotherapy while waiting for disease control; or, in selected cases, as primary therapy, mainly when surgery is not an option. The adrenal-directed drug ketoconazole is the most commonly used drug, mainly because of its rapid action, whereas the glucocorticoid receptor antagonist, mifepristone, is highly effective in controlling clinical comorbidities, mainly glucose intolerance, thus being a useful treatment for CD when it is associated with diabetes mellitus. Pituitary-directed drugs have the advantage of acting at the site responsible for CD, the pituitary tumor. Among this group of drugs, the dopamine agonist cabergoline and the somatostatin analog pasireotide result in disease remission in a consistent subgroup of patients with CD. Recently, pasireotide has been approved for the treatment of CD when surgery has failed or when surgery is not an option, and mifepristone has been approved for the treatment of Cushing's syndrome when associated with impairment of glucose metabolism in case of the lack of a surgical indication. Recent experience suggests that the combination of different drugs may be able to control cortisol excess in a great majority of patients with CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 641
Effects of Amino-glutethimide on Adrenal Function in Man1
Fishman, L. M., Liddle, G. W., Island, D. P., Fleischer, N., & Kuchel, O. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-4-481 · Cited by 155
Cushing' Disease: Management by Transsphenoidal Pituitary Microsurgery*
Bigos, S. T., Somma, M., Rasio, E., Eastman, R. C., Lanthier, A., Johnston, H. H., & HANRDY, J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-348 · Cited by 155
MUNEMURA, M., COTE, T. E., Tsuruta, K., Eskay, R. L., Kebabian, J. W., & Long, R. E. (1980) · Endocrinology · doi:10.1210/endo-107-6-1676 · Cited by 155
Vilar, L., Naves, L. A., Azevedo, M. F., Arruda, M. J., Arahata, C. M., Silva, L. M. E., Agra, R., Pontes, L., Montenegro, L., Albuquerque, J. L., et al. (2009) · Pituitary · doi:10.1007/s11102-009-0209-8 · Cited by 154
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years
Hassan-Smith, Z. K., Sherlock, M., Reulen, R. C., Arlt, W., Ayuk, J., Toogood, A. A., Cooper, M. S., Johnson, A. P., & Stewart, P. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2957 · Cited by 153
Use of Ketoconazole in the Treatment of Cushing’s Syndrome
Loli, P., Berselli, M. E., & Tagliaferri, M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1365 · Cited by 153
Pivonello, R., Matrone, C., Filippella, M., Cavallo, L. M., Somma, C. D., Cappabianca, P., Colao, A., Annunziato, L., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030859 · Cited by 152
Self-citationMetabolic Syndrome in Cushing’s Syndrome
Chanson, P., & Salenave, S. (2010) · Neuroendocrinology · doi:10.1159/000314272 · Cited by 152
Dickerman, R. D., & Oldfield, E. H. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.6.1343 · Cited by 151
Clinical Correlates of Major Depression in Cushing’s Disease
Sonino, N., Fava, G. A., Raffi, A. R., Boscaro, M., & Fallo, F. (1998) · Psychopathology · doi:10.1159/000029054 · Cited by 150
The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome
Malerbi, D. A. C., Mendonca, B. B., Liberman, B., Toledo, S. P. A., Corradini, M. C. M., Cunha-Neto, M. B. C., Fragoso, M. C. B. V., & WAJCHENBERG, B. L. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00341.x · Cited by 150
Guilhaume, B., BERTAGNA, X. Y., THOMSEN, M., Bricaire, C., Vila‐Porcile, É., Olivier, L., Racadot, J., Derome, P., Laudat, M. H., Girard, F., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-1056 · Cited by 150
Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up
Ntali, G., Asimakopoulou, A., Siamatras, T., Komninos, J., Vassiliadi, D., Tzanela, M., Tsagarakis, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0569 · Cited by 149
Lindsay, J. R., Oldfield, E. H., Stratakis, C. A., & Nieman, L. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0456 · Cited by 149
Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features
Dorn, L. D., Burgess, E. S., Dubbert, B. K., Simpson, S., Friedman, T. C., Kllng, M., Gold, P. W., & Chrousos, G. P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02614.x · Cited by 149
Newell-Price, J. D. C., Morris, D. G., Drake, W. M., Korbonits, M., Monson, J. P., BESSER, G. M., & Grossman, A. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8357 · Cited by 148
Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing’s Disease1
Devoe, D. J., Miller, W. L., Conte, F. A., Kaplan, S. L., Grumbach, M. M., Rosenthal, S. M., Wilson, C. B., & Gitelman, S. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4290 · Cited by 147
Mortality in Cushing's syndrome: a systematic review and meta-analysis.
Graversen, D., Vestergaard, P., Stochholm, K., Gravholt, C., & Jørgensen, J. O. (2012) · European journal of internal medicine · doi:10.1016/j.ejim.2011.10.013 · Cited by 147
Long‐term Results of Total Adrenalectomy for Cushing's Disease
Nagesser, S. K., van Seters, A. P., Kievit, J., Hermans, J., Krans, H. M. J., & van de Velde, C. J. �. (2000) · World Journal of Surgery · doi:10.1007/s002689910020 · Cited by 146
Surgical treatment of Cushing's disease
Chandler, W. F., SCHTEINGART, D. E., Lloyd, R. V., et al. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.66.2.0204 · Cited by 145
Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma
Kelly, D. F., Laws, E. R., & Fossett, D. T. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.2.0363 · Cited by 144
Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease
Ambrosi, B., Dall’Asta, C., Cannavò, S., Libé, R., Vigo, T., Epaminonda, P., Chiodini, I., Ferrero, S., Trimarchi, F., Arosio, M., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510173 · Cited by 143
Transsphenoidal Surgery for Pituitary Adenomas in Children
Dyer, E. H., Civit, T., Visot, A., et al. (1994) · Neurosurgery · doi:10.1227/00006123-199402000-00001 · Cited by 142
Dopamine receptor agonists for treating prolactinomas
Colao, A., Somma, C. D., Lombardi, G., Pivonello, R., & Sarno, A. D. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.6.787 · Cited by 141
Self-citationDNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU‐486.
Bourgeois, S., Pfahl, M., & Baulieu, E. E. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01879.x · Cited by 140
Transsphenoidal Surgery for Cushing's Disease: Endocrinological Follow-up Monitoring of 82 Patients
Shimon, I., Ram, Z., Cohen, Z. R., & Hadani, M. (2002) · Neurosurgery · doi:10.1097/00006123-200207000-00008 · Cited by 140
Howlett, T. A., Plowman, P. N., Wass, J. A. H., REES, L. H., Jones, A. E., & BESSER, G. M. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01255.x · Cited by 140
Liu, N., Jiang, H., Ben-Shlomo, A., Wawrowsky, K., Fan, X., Lin, S., & Melmed, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018091108 · Cited by 140
Prevedello, D. M., Pouratian, N., Sherman, J. H., Jane, J. A., Vance, M. L., Lopes, M. B. S., & Laws, E. R. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/10/0751 · Cited by 139
OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE
Patil, C. G., Veeravagu, A., Prevedello, D. M., Katznelson, L. J., Vance, M. L., & Laws, E. R. (2008) · Neurosurgery · doi:10.1227/01.neu.0000313117.35824.9f · Cited by 139
Gower, D. B. (1974) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(74)90051-x · Cited by 138
Gamma Knife Radiosurgery for Pituitary Adenoma: Early Results
Petrovich, Z. P., Yu, C., Giannotta, S. L., Zee, C., & Apuzzo, M. L. J. (2003) · Neurosurgery · doi:10.1227/01.neu.0000068702.00330.47 · Cited by 137
Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function
Feigl, G. C., Bonelli, C. M., Berghold, A., et al. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0415 · Cited by 136
Nelson, A. A., & Woodard, G. E. (1949) · PubMed · Cited by 135
Mifepristone (RU 486) in Cushing's syndrome
Johanssen, S., & Allolio, B. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0458 · Cited by 135
Laparoscopic Unilateral and Bilateral Adrenalectomy for Cushing's Syndrome
Fernández‐Cruz, L., Sáenz, A., Benarroch, G., Astudillo, E., Taurá, P., & Sabater, L. (1996) · Annals of Surgery · doi:10.1097/00000658-199612000-00008 · Cited by 135
Transsphenoidal Surgery for Cushing Disease: Experience With 136 Patients
Ciric, I. S., Zhao, J.-C., Du, H., Findling, J. W., Molitch, M. E., Weiss, R. E., Refetoff, S., Kerr, W. D., & Meyer, J. R. (2011) · Neurosurgery · doi:10.1227/neu.0b013e31822dda2c · Cited by 134
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma
Benveniste, R. J., King, W. A., Walsh, J. E., Lee, J. S., Delman, B. N., & Post, K. D. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.6.1004 · Cited by 134
Therapy of Cushing's syndrome with steroid biosynthesis inhibitors
Engelhardt, D., & Weber, M. M. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90267-4 · Cited by 133
Inhibition of Adrenocorticotropin Secretion by Somatostatin in Pituitary Cells in Culture*
Richardson, U. I., & Schönbrunn, A. (1981) · Endocrinology · doi:10.1210/endo-108-1-281 · Cited by 133
Jenkins, P. J., Trainer, P. J., Plowman, P. N., Shand, W. S., Grossman, A. B., Wass, J. A. H., & BESSER, G. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829606 · Cited by 133
Role of radiation therapy in clinical hormonally-active pituitary adenomas
Tsang, R. W. C., Brierley, J. D., Panzarella, T., et al. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91807-1 · Cited by 131
Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation
SCHTEINGART, D. E., TSAO, H. S., TAYLOR, C. I., MCKENZIE, A., VICTORIA, R., & THERRIEN, B. A. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-5-613 · Cited by 131
Pharmacology and toxicity of high-dose ketoconazole
Sugar, A. M., Alsip, S. G., Galgiani, J. N., Graybill, J. R., Dismukes, W. E., Cloud, G. A., Craven, P. C., & Stevens, D. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1874 · Cited by 129
A comparison of open vs laparoscopic adrenalectomy
MacGillivray, D. C., Shichman, S. J., Ferrer, F. A., & Malchoff, C. D. (1996) · Surgical Endoscopy · doi:10.1007/s004649900220 · Cited by 129
Jung‐Testas, I., & Baulieu, É.-É. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90282-3 · Cited by 129
Lamberts, S. W. J., Klijn, J. G. M., Quijada, M. D., TIMMERMANS, H. A. T., UITTERLINDEN, P., de Jong, F. H., & Birkenhäger, J. C. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-2-307 · Cited by 128
Pituitary adenomas in childhood and adolescence: Results of transsphenoidal surgery
Partington, M. D., Davis, D. H., Laws, E. R., & Scheithauer, B. W. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.2.0209 · Cited by 128
Long Term Results of Transsphenoidal Adenomectomy in Patients with Cushing's Disease
Nakane, T., Kuwayama, A., Watanabe, M., Takahashi, T., Kato, T., Ichihara, K., & Kageyama, N. (1987) · Neurosurgery · doi:10.1227/00006123-198708000-00015 · Cited by 128
Crooke's Cell Adenoma of the Pituitary
George, D. H., Scheithauer, B. W., Kovács, K., Horváth, É., William F. Young, Lloyd, R. V., & Meyer, F. B. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200310000-00005 · Cited by 128
Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures
Tindall, G. T., Herring, C. J., Clark, R. V., Adams, D. A., & Watts, N. B. (1990) · Journal of neurosurgery · doi:10.3171/jns.1990.72.3.0363 · Cited by 128
Pharmacological properties of mifepristone: toxicology and safety in animal and human studies
Sitruk-Ware, R. L., & Spitz, I. M. (2003) · Contraception · doi:10.1016/s0010-7824(03)00171-9 · Cited by 127
Psychiatric Phenomenology in Cushing's Disease
Loosen, P. T., Chambliss, B., DEBOLD, C. R., Shelton, R. C., & Orth, D. N. (1992) · Pharmacopsychiatry · doi:10.1055/s-2007-1014405 · Cited by 126
Outcomes of proton therapy for patients with functional pituitary adenomas
Wattson, D. A., Tanguturi, S. K., Spiegel, D. Y., Niemierko, A., Biller, B. M. K., Nachtigall, L. B., Bussière, M. R., Swearingen, B., Chapman, P. H., Loeffler, J. S., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.06.068 · Cited by 125
Heisler, S., Reisine, T., HOOK, V. Y. H., & Axelrod, J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6502 · Cited by 125
Patil, C. G., Lad, S. P., Harsh, G. R., Laws, E. R., & Boakye, M. (2007) · Neurosurgical FOCUS · doi:10.3171/foc.2007.23.3.9 · Cited by 125
Estrada, J., García-Uría, J., Lamas, C., Alfaro, J. J., Lucas, T., Diez, S., Salto, L., & Barceló, B. (2001) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.86.12.8069 · Cited by 124
Reimondo, G., Paccotti, P., Minetto, M. A., Termine, A., Stura, G., Bergui, M., Angeli, A., & Terzolo, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01776.x · Cited by 124
Locatelli, M., Vance, M. L., & Laws, E. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2436 · Cited by 124
Assessment of endocrine function after transsphenoidal surgery for Cushing's disease
McCance, D. R., Gordon, D. S., Fannin, T. F., Hadden, D. R., Kennedy, L., Sheridan, B., & Atkinson, A. B. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00976.x · Cited by 123
Long-term follow-up results of postoperative radiation therapy for Cushing’s disease
Minniti, G. C., Osti, M. F., Jaffrain‐Rea, M., Esposito, V., Cantore, G., & Enrici, R. M. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9344-0 · Cited by 123
Plasma concentrations and receptor binding of RU 486 and its metabolites in humans
Heikinheimo, O., Kimmo, K., Horacio, C., Spitz, I. M., Luukkainen, T., & Pekka, L. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90083-5 · Cited by 123
Retinoic Acid as a Novel Medical Therapy for Cushing’s Disease in Dogs
Castillo, V. A., Giacomini, D., Páez-Pereda, M., Stalla, J., Labeur, M. S., Theodoropoulou, M., Holsboer, F., Grossman, A. B., Stalla, G. K., & ARZT, E. S. (2006) · Endocrinology · doi:10.1210/en.2006-0414 · Cited by 123
Pivonello, R., Petersenn, S., Newell-Price, J. D. C., Findling, J. W., Gu, F., Maldonado, M., Trovato, A., Hughes, G., Salgado, L. R., Lacroix, A., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12431 · Cited by 122
Self-citationPsychosomatic aspects of Cushing’s syndrome
Sonino, N., Fallo, F., & Fava, G. A. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9123-7 · Cited by 122
Barbot, M., Albiger, N. M. E., Ceccato, F., Zilio, M., Frigo, A. C., Denaro, L., Mantero, F., & Scaroni, C. M. (2013) · Pituitary · doi:10.1007/s11102-013-0475-3 · Cited by 121
Avgerinos, P., Chrousos, G., Nieman, L., Oldfield, E., Loriaux, D., & Cutler, G. (1987) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-65-5-906 · Cited by 120
TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?
Burke, C. W., Adams, C. B. T., Esiri, M. M., Morris, C. S., & Bevan, J. S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03890.x · Cited by 120
Results of Gamma Knife surgery for Cushing's disease: Clinical article
Sheehan, J. P., Xu, Z., Salvetti, D. J., Schmitt, P. J., & Vance, M. L. (2013) · Journal of neurosurgery · doi:10.3171/2013.7.jns13217 · Cited by 119
Mitotane has a strong and a durable inducing effect on CYP3A4 activity
van Erp, N. P., Guchelaar, H.-J., Ploeger, B. A., Romijn, J. A., Hartigh, J. D., & Gelderblom, H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0956 · Cited by 118
Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood
Leinung, M. C., Kane, L. A., Scheithauer, B. W., Carpenter, P. C., Laws, E. R., & Zimmerman, D. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629245 · Cited by 118
The survival and well‐being of patients treated for Cushing’s syndrome
Pikkarainen, L., Sane, T., & Reunanen, A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00483.x · Cited by 118
Starke, R. M., Reames, D. L., Chen, C., Laws, E. R., & Jane, J. A. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31827b966a · Cited by 117
Proton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas
Petit, J. H., Biller, B. M. K., Yock, T. I., Swearingen, B., Coen, J. J., Chapman, P. H., Ancukiewicz, M., Bussière, M. R., Klibanski, A., & Loeffler, J. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1220 · Cited by 117
Long term results of transsphenoidal adenomectomy in patients with Cushing??s disease
Nakane, T., Kuwayama, A., Watanabe, M., Takahashi, T., Kato, T., Ichihara, K., & Kageyama, N. (1987) · Neurosurgery · doi:10.1097/00006123-198708000-00015 · Cited by 117
Gamma knife radiosurgery for pituitary adenomas
Izawa, M., Hayashi, M., Nakaya, K., et al. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.supplement_3.0019 · Cited by 117
Four Years’ Experiences in the Treatment of Pituitary Adenomas with Gamma Knife Radiosurgery
Lim, Y., Leem, W., Kim, T. S., Rhee, B. A., & Kim, G. K. (1998) · Stereotactic and Functional Neurosurgery · doi:10.1159/000056412 · Cited by 116
Vasopressin receptor expression and mutation analysis in corticotropin- secreting tumors
Dahia, P. L. M., Ahmed-Shuaib, A., Jacobs, R. A., Chew, S. L., Honegger, J. B., Fahlbusch, R., BESSER, G. M., & Grossman, A. B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626831 · Cited by 116
Balasubramaniam, A., Shannon, P. T., Hodaie, M., Laperrière, N., Michaels, H. B., & Guha, A. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-027 · Cited by 116
Potential Role for Retinoic Acid in Patients with Cushing's Disease
Giraldi, F. P., Ambrogio, A. G., Andrioli, M., Sanguin, F., Karamouzis, I., Corsello, S. M., Scaroni, C. M., Arvat, E., Pontercorvi, A., & Cavagnini, F. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2328 · Cited by 116
Komanicky, P., Spark, R. F., & Melby, J. C. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-5-1042 · Cited by 115
Storr, H. L., Alexandraki, K., Martin, L., Isidori, A. M., Kaltsas, G., Monson, J. P., BESSER, G. M., Matson, M. B., Evanson, J., Afshar, F., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1120 · Cited by 115
Gamma Knife Radiosurgery for Pituitary Adenomas
Hayashi, M., Izawa, M., Hiyama, H., Nakamura, S., Atsuchi, S., Sato, H., Nakaya, K., Sasaki, K., Ochiai, T., Kubo, O., et al. (1999) · Stereotactic and Functional Neurosurgery · doi:10.1159/000056446 · Cited by 115
Kelly, D. F. (2007) · Neurosurgical FOCUS · doi:10.3171/foc.2007.23.3.7 · Cited by 115
Drake, W. M., Perry, L. A., Hinds, C., Lowe, D., Reznek, R. H., & BESSER, G. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5156 · Cited by 114
Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
Breitschaft, A., Hu, K., Reséndiz, K. H., Darstein, C., & Golor, G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.011 · Cited by 113
Hypopituitarism As a Consequence of Brain Tumours and Radiotherapy
Darzy, K. H., & Shalet, S. M. (2005) · Pituitary · doi:10.1007/s11102-006-6042-4 · Cited by 113
Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatment
Cicala, M. V., & Mantero, F. (2010) · Neuroendocrinology · doi:10.1159/000314315 · Cited by 112
Dimopoulou, C., Schopohl, J., Rachinger, W., Buchfelder, M., Honegger, J. B., Reincke, M., & Stalla, G. K. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0634 · Cited by 112
Prolonged Treatment of Cushing's Disease by Ketoconazole
Sonino, N., Boscaro, M., & Mantero, F. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-4-718 · Cited by 112
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1945 · Cited by 111
Radiotherapy for pituitary adenomas: Long-term efficacy and toxicity
Erridge, S., Conkey, D., Stockton, D., Strachan, M. W. J., Statham, P. F. X., Whittle, I. R., Grant, R., Kerr, G. R., & Gregor, A. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.09.011 · Cited by 111
Theodoropoulou, M., Arzberger, T., Grübler, Y., Jaffrain‐Rea, M., Schlegel, J., Schaaf, L., Petrangeli, E., Losa, M., Stalla, G. K., & Pagotto, U. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05616 · Cited by 111
Kovács, K., Horváth, É., Syro, L. V., Uribe, H., Penagos, L. C., Ortiz, L. D., & Fadul, C. E. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.07.014 · Cited by 110
Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing's Disease
Devoe, D. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3196 · Cited by 110
Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy
Ding, D., Starke, R. M., & Sheehan, J. P. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1262-8 · Cited by 109
Lamberts, S. W. J., Uitterlinden, P., & Klijn, J. M. G. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200760 · Cited by 109
Aranda, G. B., Enseñat, J., Mora, M., Puig‐Domingo, M., de Osaba, M. J. M., Casals, G., Verger, E., Ribalta, T., Hanzu, F. A., & Halperín, I. (2014) · Pituitary · doi:10.1007/s11102-014-0567-8 · Cited by 108
Chow, J. T., Thompson, G. B., Grant, C. S., Farley, D. R., Richards, M. L., & Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03082.x · Cited by 108
Kong, D., Lee, J., Lim, D. H., Kim, K. W., Shin, H. J., Nam, D., Park, K., & Kim, J. (2007) · Cancer · doi:10.1002/cncr.22860 · Cited by 107
Lamberts, S. W. J., Bons, E. G., Bruining, H. A., & de Jong, F. H. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22688-x · Cited by 107
FITZGERALD, P. A., Aron, D. C., Findling, J. W., BROOKS, R. M., Wilson, C. B., Forsham, P. H., & TYRRELL, J. B. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-413 · Cited by 107
NEUROTRANSMITTER REGULATION OF CORTICOTROPIN‐RELEASING FACTOR IN VITRO
Jones, M. T., & Hillhouse, E. W. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41881.x · Cited by 106
Jagannathan, J., Yen, C. P., Pouratian, N., Laws, E. R., & Sheehan, J. P. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9832-5 · Cited by 106
EFFECT OF A SINGLE BOLUS OF ETOMIDATE UPON EIGHT MAJOR CORTICOSTEROID HORMONES AND PLASMA ACTH
ALLOLIO, B., DÖRR, H., STUTTMANN, R., KNORR, D., ENGELHARDT, D., & WINKELMANN, W. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb03241.x · Cited by 105
Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature
Berwaerts, J., Verhelst, J. A., Mahler, C., & Abs, R. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167552 · Cited by 104
Pouratian, N., Prevedello, D. M., Jagannathan, J., Lopes, M. B. S., Vance, M. L., & Laws, E. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0208 · Cited by 104
Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease
Oßwald, A., Plomer, E., Dimopoulou, C., Milian, M., Blaser, R., Ritzel, K., Mickisch, A., Knerr, F., Stanojević, M., Hallfeldt, K. K. J., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0214 · Cited by 104
Storr, H. L., Plowman, P. N., Carroll, P., François, I., Krassas, G. E., Afshar, F., BESSER, G. M., Grossman, A. B., & Savage, M. O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021032 · Cited by 103
LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE
Littley, M. D., Shalet, S. M., Beardwell, C. G., Ahmed, S. R., & Sutton, M. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03883.x · Cited by 103
Weber, A., Trainer, P. J., Grossman, A. B., Afshar, F., Medbak, S., Perry, L. A., Plowman, P. N., REES, L. H., BESSER, G. M., & Savage, M. O. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01888.x · Cited by 103
Rollin, G. A. F. S., Ferreira, N. P., Junges, M., Gross, J. L., & Czepielewski, M. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031170 · Cited by 103
Hameed, N., Yedinak, C. G., Brzana, J., Gultekin, S. H., Coppa, N. D., Dogan, A., Delashaw, J. B., & Fleseriu, M. (2013) · Pituitary · doi:10.1007/s11102-012-0455-z · Cited by 102
Cushingʼs Disease—18 Yearsʼ Experience
Rc, U., & George, J. M. (1981) · Medicine · doi:10.1097/00005792-198101000-00002 · Cited by 102
Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome
de Bruin, C., Feelders, R. A., Lamberts, S. W. J., & Hofland, L. J. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9082-4 · Cited by 102
Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome
Pereira, A. M., Delgado, V., Romijn, J. A., Smit, J. W. A., Bax, J. J., & Feelders, R. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0621 · Cited by 102
Wagenmakers, M. A. E. M., Netea-Maier, R. T., Prins, J. B., Dekkers, T., den Heijer, M., & Hermus, A. R. M. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0308 · Cited by 101
Joshi, S. M., Hewitt, R. J., Storr, H. L., Rezajooi, K., Ellamushi, H. E., Grossman, A. B., Savage, M. O., & Afshar, F. (2005) · Neurosurgery · doi:10.1227/01.neu.0000166580.94215.53 · Cited by 100
Neuropsychiatric Findings in Cushing Syndrome and Exogenous Glucocorticoid Administration
Starkman, M. N. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.010 · Cited by 100
Cardiovascular Disease in Cushing’s Syndrome: Heart versus Vasculature
de Leo, M., Pivonello, R., Auriemma, R., Cozzolino, A., Vitale, P., Simeoli, C., Martino, M. D. D., Lombardi, G., & Colao, A. (2010) · Neuroendocrinology · doi:10.1159/000318566 · Cited by 100
Self-citationMedical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole
Feelders, R. A., Hofland, L. J., & de Herder, W. W. (2010) · Neuroendocrinology · doi:10.1159/000314292 · Cited by 100
Serum cortisol response to transsphenoidal surgery for Cushing disease
Simmons, N. E., Alden, T. D., Thorner, M. O., & Laws, E. R. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.1.0001 · Cited by 99
Hypopituitarism After Stereotactic Radiosurgery for Pituitary Adenomas
Xu, Z., Vance, M. L., Schlesinger, D. J., & Sheehan, J. P. (2012) · Neurosurgery · doi:10.1227/neu.0b013e3182846e44 · Cited by 99
Salenave, S., Gatta‐Cherifi, B., Pecheur, S., San‐Galli, F., Visot, A., Lasjaunias, P. L., Roger, P., Berge, J., Young, J., Tabarin, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031908 · Cited by 99
Barber, T. M., Adams, E. F., Ansorge, O., Byrne, J. V., Karavitaki, N., & Wass, J. A. H. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0466 · Cited by 98
Boutillier, A., Monnier, D., Lorang, D., Lundblad, J. R., Roberts, J. L., & Loeffler, J.-P. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.6.8592520 · Cited by 97
BERTAGNA, X. Y., & Guignat, L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3200 · Cited by 97
Dopamine D2 Receptor Gene Expression in Human Adenohypophysial Adenomas
Ştefăneanu, L., Kovács, K., Horváth, É., Buchfelder, M., Fahlbusch, R., & Lancranjan, I. (2001) · Endocrine · doi:10.1385/endo:14:3:329 · Cited by 97
Nyman, Y., von Hofsten, K., Palm, C., Eksborg, S., & Lönnqvist, P. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael187 · Cited by 97
Octreotide exerts different effects in vivo and in vitro in Cushing's disease
Stalla, G. K., Brockmeier, S. J., Renner, U., Newton, C., Buchfelder, M., Stalla, J., & Müller, O. A. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300125 · Cited by 96
Cerebral atrophy in Cushing's disease.
Simmons, N. E., Do, H. M., Lipper, M. H., & Laws, E. R. (2000) · Surgical Neurology · doi:10.1016/s0090-3019(99)00197-4 · Cited by 96
BIOLOGICAL STUDIES ON AN ADRENOCORTICOLYTIC AGENT AND THE ISOLATION OF THE ACTIVE COMPONENTS123
Cueto, C., & BROWN, J. H. U. (1958) · Endocrinology · doi:10.1210/endo-62-3-334 · Cited by 95
Post-operative diabetes insipidus after endoscopic transsphenoidal surgery
Schreckinger, M., Walker, B., Knepper, J. P., Hornyak, M., Hong, D., Kim, J., Folbe, A. J., Guthikonda, M., Mittal, S., & Szerlip, N. J. (2012) · Pituitary · doi:10.1007/s11102-012-0453-1 · Cited by 94
Toja, P. M., Branzi, G., Ciambellotti, F., Radaelli, P., Martin, M. D., Lonati, L. M., Scacchi, M., Parati, G., Cavagnini, F., & Giraldi, F. P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04206.x · Cited by 94
Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center
Yaneva, M., Kalinov, K., & Zacharieva, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0320 · Cited by 93
Predictive Factors for Initial Cure and Relapse Rate After Pituitary Surgery for Cushing’s Disease
PIETERS, G. F. F. M., Hermus, A. R. M. M., MEIJER, E., SMALS, A. G. H., & KLOPPENBORG, P. W. C. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1122 · Cited by 93
Neary, N. M., Booker, O. J., Abel, B. S., Matta, J. R., Muldoon, N., Sinaii, N., Pettigrew, R. I., Nieman, L. K., & Gharib, A. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3754 · Cited by 93
Netea-Maier, R. T., van Lindert, E. J., den Heijer, M., van der Eerden, A. W., PIETERS, G. F. F. M., Sweep, F. C. G. J., Grotenhuis, J. A., & Hermus, A. R. M. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02133 · Cited by 92
Modern techniques for pituitary radiotherapy
Minniti, G. C., Gilbert, D. C., & Brada, M. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9106-0 · Cited by 92
Gamma-Knife Surgery for Secreting Pituitary Adenomas
Morange, I., Régis, J. M., Dufour, H., Andrieu, J., Grisoli, F., Jaquet, P., & Péragut, J. C. (1998) · Acta Neurochirurgica · doi:10.1007/s007010050121 · Cited by 91
Medical management of Cushing’s disease: what is the future?
Fleseriu, M., & Petersenn, S. (2012) · Pituitary · doi:10.1007/s11102-012-0397-5 · Cited by 91
A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome
Valassi, E., Crespo, I., Gich, I., Rodríguez, J., & Webb, S. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04424.x · Cited by 91
Peace, Orme, Padayatty, Godfrey, & Belchetz (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00543.x · Cited by 90
Hyperhomocysteinemia in Patients with Cushing’s Syndrome
Terzolo, M., Allasino, B., Bosio, S., Brusa, E., Daffara, F., Ventura, M., Aroasio, E., Sacchetto, G., Reimondo, G., Angeli, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0079 · Cited by 90
Role of oxytocin in the ejaculatory process.
Pivonello, R., Ferone, D., Filippella, M., Faggiano, A., Martino, M. C. D., Auriemma, R. S., Rota, F., Lombardi, G., & Colao, A. (2003) · PubMed · Cited by 89
Self-citationWagenmakers, M. A. E. M., Boogaarts, H. D., Roerink, S. H. P. P., Timmers, H. J. L. M., Stikkelbroeck, N. M. M. L., Smit, J. W. A., van Lindert, E. J., Netea-Maier, R. T., Grotenhuis, J. A., & Hermus, A. R. M. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0325 · Cited by 89
The Efficacy of Linear Accelerator Radiosurgery in the Management of Patients with Cushing’s Disease
Devin, J. K., Allen, G. S., Cmelak, A. J., Duggan, D. M., & Blevins, L. S. (2004) · Stereotactic and Functional Neurosurgery · doi:10.1159/000083476 · Cited by 89
Fleseriu, M., Findling, J. W., Koch, C. A., Schlaffer, S.-M., Buchfelder, M., & Gross, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1843 · Cited by 89
Cushing’s Disease in Childhood: Presentation, Investigation, Treatment and Long-Term Outcome
Savage, M. O., Lienhardt, A., Lebrethon, M. C., Johnston, L., Huebner, A., Grossman, A. B., Afshar, F., Plowman, P. N., & BESSER, G. M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063459 · Cited by 88
Fatal Hepatitis Associated With Ketoconazole Therapy
Duarte, P. A., Chow, C. C., Simmons, F., & Ruskin, J. N. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350170237037 · Cited by 87
Bilateral Adrenalectomy for Refractory Cushing Disease: A Safe and Definitive Therapy
Smith, P. W., Turza, K. C., Carter, C. O., Vance, M. L., Laws, E. R., & Hanks, J. B. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.02.054 · Cited by 87
Neurosurgical Treatment of Nelson’s Syndrome
Kelly, P. A., Samandouras, G., Grossman, A. B., Afshar, F., Besser, G. M., & Jenkins, P. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020299 · Cited by 87
Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome
Tabarin, A., Navarranne, A., Guerin, J. B., Corcuff, J., Parneix, M., & Roger, P. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01737.x · Cited by 86
de Keyzer, Y., René, P., Beldjord, C., Lenne, F., & BERTAGNA, X. Y. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00560.x · Cited by 86
Cushing's syndrome: aftermath of the cure
Pivonello, R., De Martino, M. C., De Leo, M., Tauchmanovà, L., Faggiano, A., Lombardi, G., & Colao, A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800025 · Cited by 85
Self-citationCushing’s Syndrome in Children and Adolescents
Mastorakos, G. P., & Kanaka‐Gantenbein, C. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_9 · Cited by 85
Hart, M. M., Reagan, R. L., & Adamson, R. H. (1973) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(73)90185-3 · Cited by 85
Krakoff, J. A., Koch, C. A., Calis, K. A., Alexander, R. H., & Nieman, L. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7870 · Cited by 85
Greening, J. E., Brain, C. E., Perry, L. A., Mushtaq, I., Marques, J. S., Grossman, A. B., & Savage, M. O. (2005) · Hormone Research in Paediatrics · doi:10.1159/000088587 · Cited by 85
Single-center experience with pediatric Cushing's disease
Kanter, A. S., Diallo, A. O., Jane, J. A., Sheehan, J. P., Asthagiri, A. R., Oskouian, R. J., Okonkwo, D. O., Sansur, C. A., Vance, M. L., Rogol, A. D., et al. (2005) · Journal of neurosurgery · doi:10.3171/ped.2005.103.5.0413 · Cited by 85
The Diagnosis of Cushing's Syndrome
Boscaro, M., Barzon, L., & Sonino, N. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.20.3045 · Cited by 84
Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach
Jane, J. A., Vance, M. L., Woodburn, C. J., & Laws, E. R. (2003) · Neurosurgical FOCUS · doi:10.3171/foc.2003.14.5.13 · Cited by 84
Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors
Pivonello, R., Ferone, D., de Herder, W. W., de Krijger, R. R., Waaijers, M., Mooij, D. M., van Koetsveld, P. M., Barreca, A., De, M. D. B., Lombardi, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031746 · Cited by 84
Self-citationDrugs in the medical treatment of Cushing's syndrome
SCHTEINGART, D. E. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903413522 · Cited by 83
Etomidate for emergency anaesthesia; mad, bad and dangerous to know?
Morris, C., & McAllister, C. (2005) · Anaesthesia · doi:10.1111/j.1365-2044.2005.04325.x · Cited by 83
Giraldi, F. P., Scaroni, C. M., Arvat, E., Martin, M. D., Giordano, R., Albiger, N. M. E., Leão, A. A. S., Picu, A., Mantero, F., & Cavagnini, F. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02452.x · Cited by 82
Effect of Pioglitazone on Adrenocorticotropic Hormone and Cortisol Secretion in Cushing’s Disease
Suri, D., & Weiss, R. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1746 · Cited by 82
Laparoscopic Adrenalectomy for Adrenocorticotropin-Dependent Cushing's Syndrome
Vella, A. V., Thompson, G. B., Grant, C. S., van Heerden, J. A., Farley, D. R., & Young, W. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7399 · Cited by 82
Pituitary Tumors and Gamma Knife Surgery - Clinical Experience with More Than Two Years of Follow-Up
Martínez, R., Bravo, G., Burzaco, J., et al. (1998) · Stereotactic and Functional Neurosurgery · doi:10.1159/000056413 · Cited by 81
Tommasi, C. D., Vance, M. L., Okonkwo, D. O., Diallo, A. O., & Laws, E. R. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.5.0825 · Cited by 81
Bilateral adrenalectomy: low mortality and morbidity in Cushing's disease
McCance, D. R., Russell, C. F. J., Kennedy, T. L., Hadden, D. R., Kennedy, L., & Atkinson, A. B. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02371.x · Cited by 81
Adrenocortical suppression by a single induction dose of etomidate
Allolio, B., Stuttmann, R., Leonhard, U., Fischer, H., & Winkelmann, W. (1984) · Journal of Molecular Medicine · doi:10.1007/bf01711723 · Cited by 80
Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas
Cannavò, S., Almoto, B., Dall’Asta, C., Corsello, S. M., Lovicu, R. M., Menis, E. D., Trimarchi, F., & Ambrosi, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490195 · Cited by 80
Is diabetes in Cushing’s syndrome only a consequence of hypercortisolism?
Giordano, C., Guarnotta, V., Pivonello, R., Amato, M. C., Simeoli, C., Ciresi, A., Cozzolino, A., & Colao, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0754 · Cited by 79
Self-citationThe Nelson's syndrome... revisited
Assié, G., Bahurel-Barrera, H., Bertherat, J. Y., Kujas, M., Legmann, P., & BERTAGNA, X. Y. (2004) · Pituitary · doi:10.1007/s11102-005-1403-y · Cited by 78
Renner, U., Arzberger, T., Pagotto, U., Leimgruber, S., Uhl, E., Müller, A., Lange, M., Weindl, A., & Stalla, G. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4685 · Cited by 77
EFFECTS OF o,p' DDD1ON HISTOLOGY AND 17- HYDROXYCORTICOSTEROID OUTPUT OF THE DOG ADRENAL CORTEX1
Vilar, O., & Tullner, W. W. (1959) · Endocrinology · doi:10.1210/endo-65-1-80 · Cited by 77
CLINICAL EXPERIENCE WITH KETOCONAZOLE AS A THERAPY FOR PATIENTS WITH CUSHING'S SYNDROME
McCance, D. R., Hadden, D. R., Kennedy, L., Sheridan, B., & Atkinson, A. B. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01189.x · Cited by 77
Blevins, L. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.63 · Cited by 77
Ketoconazole Inhibits Corticotropic Cell Functionin Vitro*
Stalla, G. K., Stalla, J., HUBER, M., Loeffler, J., Höllt, V., von Werder, K., & Müller, O. A. (1988) · Endocrinology · doi:10.1210/endo-122-2-618 · Cited by 76
Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome.
Ds, O., Farley, D. R., Young, W. F., Cs, G., & van Heerden, J. A. (1994) · PubMed · Cited by 76
Cushing’s syndrome complicated by multiple opportunistic infections
Bakker, R. C., Gallas, P., Romijn, J. A., & Wiersinga, W. M. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350337 · Cited by 75
Sheehan, J. M., Lopes, M. B. S., Sheehan, J. P., Ellegala, D. B., Webb, K. M., & Laws, E. R. (2000) · Neurosurgery · doi:10.1097/00006123-200007000-00008 · Cited by 74
Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease
Acebes, J. J., Martino, J., Aumatell, C. M., Montanya, E., & Soler, J. (2007) · Acta Neurochirurgica · doi:10.1007/s00701-007-1133-1 · Cited by 74
Yamada, S., Fukuhara, N., Nishioka, H., Takeshita, A., Inoshita, N., Itô, J., & Takeuchi, Y. (2011) · World Neurosurgery · doi:10.1016/j.wneu.2011.06.033 · Cited by 74
Thiazolidinediones: A Comparative Review of Approved Uses
Sood, V., Colleran, K., & Burge, M. R. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050194297 · Cited by 74
Cronin, M. J., Cheung, C. Y., Wilson, C. B., Jaffe, R. B., & Weiner, R. I. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-387 · Cited by 73
Lila, A. R., Gopal, R. A., Acharya, S. V., George, J., Sarathi, V., Bandgar, T., Menon, P. S., & Shah, N. S. (2010) · Endocrine Practice · doi:10.4158/ep10031.or · Cited by 72
Treatment of Cushing's Disease in Childhood and Adolescence by Stereotactic Pituitary Irradiation
Thoren, M., Rähn, T., Hallengren, B., et al. (1986) · Acta Paediatrica · doi:10.1111/j.1651-2227.1986.tb10219.x · Cited by 72
Casulari, L. A., Naves, L. A., de Mello, P. A., Neto, A. P., & Papadia, C. (2004) · Hormone Research in Paediatrics · doi:10.1159/000082235 · Cited by 72
Efficacy of medical treatment in C ushing's disease: a systematic review
Gadelha, M. R., & Neto, L. V. (2013) · Clinical Endocrinology · doi:10.1111/cen.12345 · Cited by 72
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing’s disease
Storr, H. L., Afshar, F., Matson, M. B., Sabin, H. I., Davies, K. M., Evanson, J., Plowman, P. N., BESSER, G. M., Monson, J. P., Grossman, A. B., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01921 · Cited by 72
Leiba, S., Weinstein, R. S., Schindel, B., Lapidot, M., Stern, E., Levavi, H., Rusecki, Y., & ABRAMOVICI, A. (1989) · PubMed · Cited by 72
Ambrosi, B., Bochicchio, D., Fadin, C., Colombo, P., & Faglia, G. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349555 · Cited by 71
Swearingen, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3237 · Cited by 71
Predicting relapse after transsphenoidal surgery for Cushing's disease
Toms, G. C., McCarthy, M. I., Niven, M. J., Orteu, C. H., King, T. T., & Monson, J. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432771 · Cited by 71
Medical Treatment of Cushing’s Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone
Castinetti, F., Conte‐Devolx, B., & Brue, T. C. (2010) · Neuroendocrinology · doi:10.1159/000314224 · Cited by 71
Treatment of Cushing's Disease
Temple, T. E., Jones, D. J., Liddle, G. W., & Dexter, R. N. (1969) · New England Journal of Medicine · doi:10.1056/nejm196910092811501 · Cited by 71
Strowski, M. Z., Dashkevicz, M. P., Parmar, R. M., Wilkinson, H. A., Köhler, M. G., Schaeffer, J. M., & Blake, A. D. (2002) · Neuroendocrinology · doi:10.1159/000059430 · Cited by 70
Gamma Knife Surgery for Sellar and Suprasellar Tumors
Stephanian, E., Lunsford, L. D., Coffey, R. J., Bissonette, D. J., & Flíckinger, J. C. (1992) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30689-2 · Cited by 70
Research works printed but not linked: 143
- Lüdecke, 1976, Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases, Acta Neurochir (Wien), 35, 27, 10.1007/BF01405930 · doi:10.1007/bf01405930
- Carmalt, 1977, The treatment of Cushing's disease by trans-sphenoidal hypophysectomy, Q J Med, 46, 119
- Wajchenberg, 1979, Evaluation of resection of pituitary microadenoma for the treatment of Cushing's disease in patients with radiologically normal sella turcica, Clin Endocrinol (Oxf), 11, 323, 10.1111/j.1365-2265.1979.tb03081.x · doi:10.1111/j.1365-2265.1979.tb03081.x
- Hardy, 1982, Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later, Can J Neurol Sci, 9, 375, 10.1017/S0317167100044279 · doi:10.1017/s0317167100044279
- Thomas, 1983, Long term results of radical hypophysectomy for Cushing's disease, Clin Endocrinol (Oxf), 19, 629, 10.1111/j.1365-2265.1983.tb00041.x · doi:10.1111/j.1365-2265.1983.tb00041.x
- Brand, 1985, Long-term follow up of trans-sphenoidal hypophysectomy for Cushing's disease, J R Soc Med, 78, 291, 10.1177/014107688507800404 · doi:10.1177/014107688507800404
- Tagliaferri, 1986, Transsphenoidal microsurgery for Cushing's disease, Acta Endocrinol (Copenh), 113, 5, 10.1530/acta.0.1130005 · doi:10.1530/acta.0.1130005
- van Aken, 1997, Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease, Clin Endocrinol (Oxf), 47, 145, 10.1046/j.1365-2265.1997.2541051.x · doi:10.1046/j.1365-2265.1997.2541051.x
- Vignati, 1994, Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease, Eur J Endocrinol, 130, 235, 10.1530/eje.0.1300235 · doi:10.1530/eje.0.1300235
- Powell, 2009, Microscope and endoscopic pituitary surgery, Acta Neurochirurgica, 151, 723, 10.1007/s00701-009-0297-2 · doi:10.1007/s00701-009-0297-2
- Ciric, 2002, Transsphenoidal microsurgery, Neurosurgery, 51, 161, 10.1097/00006123-200207000-00023 · doi:10.1097/00006123-200207000-00023
- Ciric, 2006, Transsphenoidal microsurgery: past, present and future, Expert Rev Anticancer Ther, 6, S75, 10.1586/14737140.6.9s.S75 · doi:10.1586/14737140.6.9s.s75
- Cappabianca, 1998, Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS), Minim Invasive Neurosurg, 41, 66, 10.1055/s-2008-1052019 · doi:10.1055/s-2008-1052019
- Cappabianca, 2004, Endoscopic endonasal transsphenoidal surgery, Neurosurgery, 55, 933, 10.1227/01.NEU.0000137330.02549.0D · doi:10.1227/01.neu.0000137330.02549.0d
- Strychowsky, 2011, Purely endoscopic transsphenoidal surgery versus traditional microsurgery for resection of pituitary adenomas: systematic review, J Otolaryngol Head Neck Surg, 40, 175
- Laws, 2014, The transition from microscopic to endoscopic transsphenoidal surgery: the experience at Brigham and Women's Hospital, World Neurosurg, 82, S152, 10.1016/j.wneu.2014.07.035 · doi:10.1016/j.wneu.2014.07.035
- Haddad, 1991, Pediatric pituitary tumors, Neurosurgery, 29, 509, 10.1227/00006123-199110000-00004 · doi:10.1227/00006123-199110000-00004
- Mehrazin, 2007, Pituitary tumors in children: clinical analysis of 21 cases, Childs Nerv Syst, 23, 391, 10.1007/s00381-006-0259-4 · doi:10.1007/s00381-006-0259-4
- Doniach, 1977, Histopathology of the anterior pituitary, Clin Endocrinol Metab, 6, 21, 10.1016/S0300-595X(77)80055-8 · doi:10.1016/s0300-595x(77)80055-8
- Kovács, 2013, ACTH-secreting Crooke cell carcinoma of the pituitary, Eur J Clin Invest, 43, 20, 10.1111/eci.12010 · doi:10.1111/eci.12010
- Felix, 1981, Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases, Acta Neurochir (Wien), 58, 235, 10.1007/BF01407130 · doi:10.1007/bf01407130
- Jho, 1996, Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note, Acta Neurochir (Wien), 138, 1416, 10.1007/BF01411120 · doi:10.1007/bf01411120
- Cappabianca, 2002, Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas, J Neurosurg, 97, 293, 10.3171/jns.2002.97.2.0293 · doi:10.3171/jns.2002.97.2.0293
- Zada, 2010, Intraoperative conversion from endoscopic to microscopic approach for the management of sellar pathology: incidence and rationale in a contemporary series, World Neurosurg, 73, 334, 10.1016/j.wneu.2010.02.069 · doi:10.1016/j.wneu.2010.02.069
- Murty, 1990, Early inappropriate secretion of antidiuretic hormone after trans-sphenoidal pituitary adenomectomy, J Laryngol Otol, 104, 894, 10.1017/S0022215100114288 · doi:10.1017/s0022215100114288
- Ultmann, 1992, Transient hyponatremia after damage to the neurohypophyseal tracts, Neuroendocrinology, 56, 803, 10.1159/000126310 · doi:10.1159/000126310
- Levy, 1991, Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients, Stereotact Funct Neurosurg, 57, 22, 10.1159/000099553 · doi:10.1159/000099553
- Edmonds, 1972, External irradiation of the hypophysis for Cushing's disease, Can Med Assoc J, 107, 860
- Ahmed, 1984, Treatment of Cushing's disease with low dose radiation therapy, Br Med J Clin Res Ed, 289, 643, 10.1136/bmj.289.6446.643 · doi:10.1136/bmj.289.6446.643
- Vicente, 1991, Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease, Acta Endocrinol (Copenh), 125, 470, 10.1530/acta.0.1250470 · doi:10.1530/acta.0.1250470
- Grigsby, 1988, Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents, Am J Clin Oncol, 11, 607, 10.1097/00000421-198812000-00001 · doi:10.1097/00000421-198812000-00001
- Degerblad, 1986, Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease, Acta Endocrinol (Copenh), 112, 310, 10.1530/acta.0.1120310 · doi:10.1530/acta.0.1120310
- Ganz, 1993, The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact, Funct Neurosurg, 61, 30, 10.1159/000100657 · doi:10.1159/000100657
- Inoue, 1999, Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: experience in 122 cases, Stereotact Funct Neurosurg, 72, 125, 10.1159/000056448 · doi:10.1159/000056448
- Mokry, 1999, A six year experience with the postoperative radiosurgical management of pituitary adenomas, Stereotact Funct Neurosurg, 72, 88, 10.1159/000056444 · doi:10.1159/000056444
- Shin, 2000, Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus, J Neurosurg, 93, 2, 10.3171/jns.2000.93.supplement_3.0002 · doi:10.3171/jns.2000.93.supplement_3.0002
- Kobayashi, 2002, Gamma knife radiosurgery in the treatment of Cushing disease: long-term results, J Neurosurg, 97, 422, 10.3171/jns.2002.97.supplement_5.0422 · doi:10.3171/jns.2002.97.supplement_5.0422
- Wong, 2003, LINAC radiosurgery in recurrent Cushing's disease after transsphenoidal surgery: a series of 5 cases, Minim Invasive Neurosurg, 46, 327, 10.1055/s-2003-812497 · doi:10.1055/s-2003-812497
- Choi, 2003, Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery, Yonsei Med J, 44, 602, 10.3349/ymj.2003.44.4.602 · doi:10.3349/ymj.2003.44.4.602
- Kajiwara, 2005, Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas, Minim Invasive Neurosurg, 48, 91, 10.1055/s-2004-830261 · doi:10.1055/s-2004-830261
- Zeiler, 2013, Gamma knife in the treatment of pituitary adenomas: results of a single center, Can J Neurol Sci, 40, 546, 10.1017/S0317167100014645 · doi:10.1017/s0317167100014645
- Kim, 1999, Gamma Knife radiosurgery for functioning pituitary microadenoma, Stereotact Funct Neurosurg, 72, 119, 10.1159/000056447 · doi:10.1159/000056447
- Landolt, 2000, Gamma knife radiosurgery for prolactinomas, J Neurosurg, 93, 14, 10.3171/jns.2000.93.supplement_3.0014 · doi:10.3171/jns.2000.93.supplement_3.0014
- Aristizabal, 1977, Relationship of time dose factors to tumor control and complications in the treatment of Cushing's disease by irradiation, Int J Radiat Oncol Biol Phys, 2, 47, 10.1016/0360-3016(77)90007-4 · doi:10.1016/0360-3016(77)90007-4
- Chen, 2001, Radiosurgical management of benign cavernous sinus tumors: dose profiles and acute complications, Neurosurgery, 48, 1022
- Ove, 2000, Preservation of visual fields after peri-sellar gamma-knife radiosurgery, Int J Cancer, 90, 343, 10.1002/1097-0215(20001220)90:6<343::AID-IJC6>3.0.CO;2-H · doi:10.1002/1097-0215(20001220)90:6<343::aid-ijc6>3.0.co;2-h
- Mehta, 1993, Cavernous sinus cranial neuropathies: is there a dose-response relationship following radiosurgery?, Int J Radiat Oncol Biol Phys, 27, 477, 10.1016/0360-3016(93)90262-T · doi:10.1016/0360-3016(93)90262-t
- Liu, 2005, Gamma knife radiosurgery for tumors involving the cavernous sinus, Stereotact Funct Neurosurg, 83, 45, 10.1159/000085544 · doi:10.1159/000085544
- Kuo, 2004, Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes, Neurosurgery, 54, 1385, 10.1227/01.NEU.0000124750.13721.94 · doi:10.1227/01.neu.0000124750.13721.94
- Lundström, 1976, Atrophy of optic nerve fibres in compression of the chiasm. Degree and distribution of ophthalmoscopic changes, Acta Ophthalmol (Copenh), 54, 623, 10.1111/j.1755-3768.1976.tb01291.x · doi:10.1111/j.1755-3768.1976.tb01291.x
- Abe, 2002, Early palliation of oculomotor nerve palsy following gamma knife radiosurgery for pituitary adenoma, Eur Neurol, 47, 61, 10.1159/000047951 · doi:10.1159/000047951
- Packer, 2002, Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation, Curr Neurol Neurosci Rep, 2, 131, 10.1007/s11910-002-0021-6 · doi:10.1007/s11910-002-0021-6
- Guinan, 1998, Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients, J Neurol Neurosurg Psychiatry, 65, 870, 10.1136/jnnp.65.6.870 · doi:10.1136/jnnp.65.6.870
- Niranjan, 2009, Neoplastic transformation after radiosurgery or radiotherapy: risk and realities, Otolaryngol Clin North Am, 42, 717, 10.1016/j.otc.2009.04.005 · doi:10.1016/j.otc.2009.04.005
- Jones, 1991, Radiation oncogenesis in relation to the treatment of pituitary tumours, Clin Endocrinol (Oxf), 35, 379, 10.1111/j.1365-2265.1991.tb03554.x · doi:10.1111/j.1365-2265.1991.tb03554.x
- Wu-Chen, 2009, Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma, J Neuroophthalmol, 29, 289, 10.1097/WNO.0b013e3181b4a1be · doi:10.1097/wno.0b013e3181b4a1be
- Ecemis, 2013, Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgery, Expert Rev Neurother, 13, 557, 10.1586/ern.13.37 · doi:10.1586/ern.13.37
- Tsukamoto, 1992, Meningioma developed 25 years after radiation therapy for Cushing's disease, Intern Med, 31, 629, 10.2169/internalmedicine.31.629 · doi:10.2169/internalmedicine.31.629
- Sarkar, 2014, Radiation-induced opticochiasmatic glioblastoma multiforme following conventional radiotherapy for Cushing's disease, Br J Neurosurg, 28, 510, 10.3109/02688697.2013.841850 · doi:10.3109/02688697.2013.841850
- Larson, 1993, The radiobiology of radiosurgery, Int J Radiat Oncol Biol Phys, 25, 557, 10.1016/0360-3016(93)90080-F · doi:10.1016/0360-3016(93)90080-f
- Croughs, 1971, Immediate effect of unilateral adrenalectomy followed by external pituitary irradiation on cortisol secretion rate in subjects suffering from pituitary dependent Cushing's syndrome, J Clin Endocrinol Metab, 33, 912, 10.1210/jcem-33-6-912 · doi:10.1210/jcem-33-6-912
- Lamberts, 1977, Evaluation of a therapeutic regimen in Cushing's disease. The predictability of the result of unilateral adrenalectomy followed by external pituitary irradiation, Acta Endocrinol (Copenh), 86, 146, 10.1530/acta.0.0860146 · doi:10.1530/acta.0.0860146
- Landau, 1978, Unilateral adrenalectomy and pituitary irradiation in the treatment of ACTH-dependent Cushing's disease in children and adolescents, Clin Endocrinol (Oxf), 9, 221, 10.1111/j.1365-2265.1978.tb02203.x · doi:10.1111/j.1365-2265.1978.tb02203.x
- Ernest, 1972, Adrenalectomy in Cushing's disease. A long-term follow-up, Acta Endocrinol Suppl (Copenh), 160, 3
- Tomita, 1981, Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment, Endocrinol Jpn, 28, 197, 10.1507/endocrj1954.28.197 · doi:10.1507/endocrj1954.28.197
- Kelly, 1983, Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients, Q J Med, 52, 224
- Bax, 1996, Laparoscopic bilateral adrenalectomy following failed hypophysectomy, Surg Endosc, 10, 1150, 10.1007/s004649900268 · doi:10.1007/s004649900268
- Chapuis, 1997, Bilateral laparoscopic adrenalectomy for Cushing's disease, Br J Surg, 84, 1009, 10.1002/bjs.1800840731 · doi:10.1002/bjs.1800840731
- Acosta, 1999, Laparoscopic versus open adrenalectomy in Cushing's syndrome and disease, Surgery, 126, 1111, 10.1067/msy.2099.102423 · doi:10.1067/msy.2099.102423
- Mikhail, 2006, Open versus laparoscopic simultaneous bilateral adrenalectomy, Urology, 67, 693, 10.1016/j.urology.2005.10.037 · doi:10.1016/j.urology.2005.10.037
- Bulus, 2013, Comparison of laparoscopic and open adrenalectomy, Acta Chir Belg, 113, 203, 10.1080/00015458.2013.11680912 · doi:10.1080/00015458.2013.11680912
- Munir, 2007, Nelson's syndrome, Arq Bras Endocrinol Metabol, 51, 1392, 10.1590/S0004-27302007000800026 · doi:10.1590/s0004-27302007000800026
- Kasperlik-Załuska, 2006, Nelson's syndrome – 46 years later: clinical experience with 37 patients, Zentralbl Neurochir, 67, 14, 10.1055/s-2006-921430 · doi:10.1055/s-2006-921430
- Xing, 2002, Microsurgical treatment of Nelson's syndrome, Chin Med J Engl, 115, 1150
- Kemink, 2001, Management of Nelson's syndrome: observations in fifteen patients, Clin Endocrinol (Oxf), 54, 45, 10.1046/j.1365-2265.2001.01187.x · doi:10.1046/j.1365-2265.2001.01187.x
- Wolffenbuttel, 1998, Beneficial gamma-knife radiosurgery in a patient with Nelson's syndrome, Clin Neurol Neurosurg, 100, 60, 10.1016/S0303-8467(97)00124-8 · doi:10.1016/s0303-8467(97)00124-8
- Moore, 1976, Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation, Ann Intern Med, 85, 731, 10.7326/0003-4819-85-6-731 · doi:10.7326/0003-4819-85-6-731
- Vik-Mo, 2009, Gamma knife stereotactic radiosurgery of Nelson syndrome, Eur J Endocrinol, 160, 143, 10.1530/EJE-08-0687 · doi:10.1530/eje-08-0687
- Gil-Cárdenas, 2007, Nelson's syndrome after bilateral adrenalectomy for Cushing's disease, Surgery, 141, 147, 10.1016/j.surg.2006.12.003 · doi:10.1016/j.surg.2006.12.003
- Kreutzer, 2009, No effect of the PPAR-γ agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo, Clin Neuropathol, 28, 430
- Moyes, 2009, Treatment of Nelson's syndrome with temozolomide, Eur J Endocrinol, 160, 115, 10.1530/EJE-08-0557 · doi:10.1530/eje-08-0557
- Berselli, 1987, Effect of ketoconazole on CRH-induced ACTH and cortisol release in patients with Cushing's disease, Horm Metab Res Suppl, 16, 58
- Tabarin, 1990, Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease [in French], Ann Endocrinol (Paris), 51, 27
- Manavela, 2001, The association of Cushing's disease and primary empty sella turcica, Pituitary, 4, 145, 10.1023/A:1015310806063 · doi:10.1023/a:1015310806063
- Kazy, 2005, Population-based case-control study of oral ketoconazole treatment for birth outcomes, Congenit Anom (Kyoto), 45, 5, 10.1111/j.1741-4520.2005.00053.x · doi:10.1111/j.1741-4520.2005.00053.x
- Chart, 1958, New amphenone analogs as adrenocortical inhibitors, Experientia, 14, 151, 10.1007/BF02157133 · doi:10.1007/bf02157133
- Dewis, 1983, Experience with trilostane in the treatment of Cushing's syndrome, Clin Endocrinol (Oxf), 18, 533, 10.1111/j.1365-2265.1983.tb00590.x · doi:10.1111/j.1365-2265.1983.tb00590.x
- Doenicke, 1994, A comparison of two formulations for etomidate, 2-hydroxypropyl-β-cyclodextrin (HPCD) and propylene glycol, Anesth Analg, 79, 933, 10.1213/00000539-199411000-00020 · doi:10.1213/00000539-199411000-00020
- Zacharias, 1979, Venous sequelae following etomidate, Br J Anaesth, 51, 779, 10.1093/bja/51.8.779 · doi:10.1093/bja/51.8.779
- Doenicke, 1997, Haemolysis after etomidate: comparison of propylene glycol and lipid formulations, Br J Anaesth, 79, 386, 10.1093/bja/79.3.386 · doi:10.1093/bja/79.3.386
- Yorgin, 1997, Propylene glycol-induced proximal renal tubular cell injury, Am J Kidney Dis, 30, 134, 10.1016/S0272-6386(97)90577-1 · doi:10.1016/s0272-6386(97)90577-1
- Hart, 1971, Studies on the site of action of o,p'-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis, Steroids, 17, 559, 10.1016/S0039-128X(71)80157-5 · doi:10.1016/s0039-128x(71)80157-5
- Southren, 1961, Effect of o,p'DDD in a patient with Cushing's syndrome, J Clin Endocrinol Metab, 21, 201, 10.1210/jcem-21-2-201 · doi:10.1210/jcem-21-2-201
- Dickerman, 1979, Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient, Isr J Med Sci, 15, 455
- Takamatsu, 1981, Does mitotane reduce endogenous ACTH secretion?, N Engl J Med, 305, 957, 10.1056/NEJM198110153051617 · doi:10.1056/nejm198110153051617
- Suda, 1983, Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease, J Clin Endocrinol Metab, 56, 1094, 10.1210/jcem-56-6-1094 · doi:10.1210/jcem-56-6-1094
- Plonk, 1976, Modification of adrenal function by the anti-serotonin agent cyproheptadine, J Clin Endocrinol Metab, 42, 291, 10.1210/jcem-42-2-291 · doi:10.1210/jcem-42-2-291
- Kriegert, 1976, Letter: cyproheptadine for pituitary disorders, N Engl J Med, 295, 394, 10.1056/NEJM197608122950715 · doi:10.1056/nejm197608122950715
- Ambrosi, 1979, Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome, Horm Metab Res, 11, 318, 10.1055/s-0028-1095778 · doi:10.1055/s-0028-1095778
- Tyrrell, 1976, More on cyproheptadine, N Engl J Med, 295, 1137, 10.1056/NEJM197611112952017 · doi:10.1056/nejm197611112952017
- Copinschi, 1977, Lack of effect of cyproheptadine in Cushing's disease and in Nelson's syndrome, Acta Endocrinol (Copenh), 312
- Koppeschaar, 1983, Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease, Acta Endocrinol (Copenh), 104, 160, 10.1530/acta.0.1040160 · doi:10.1530/acta.0.1040160
- Tucci, 1989, Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation, J Endocrinol Invest, 12, 197, 10.1007/BF03349961 · DOI
- Hsu, 1981, Cyproheptadine in the control of Cushing's disease, Johns Hopkins Med J, 149, 77
- Barnes, 1977, Cushing's disease: successful treatment with cyproheptadine, Lancet, 1, 1148, 10.1016/S0140-6736(77)92402-3 · doi:10.1016/s0140-6736(77)92402-3
- Ooi, 1987, Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma, J Endocrinol Invest, 10, 107, 10.1007/BF03347166 · doi:10.1007/bf03347166
- Middler, 1976, Letter: cyproheptadine for pituitary disorders, N Engl J Med, 295, 394, 10.1056/NEJM197608122950715 · doi:10.1056/nejm197608122950715
- Ferrari, 1977, More on cyproheptadine in Cushing's disease, N Engl J Med, 296, 576, 10.1056/NEJM197703102961022 · doi:10.1056/nejm197703102961022
- Grant, 1979, Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy, Arch Dis Child, 54, 466, 10.1136/adc.54.6.466 · doi:10.1136/adc.54.6.466
- Pearce, 1977, Treatment of Cushing's disease with cyproheptadine, Lancet, 1, 1368, 10.1016/S0140-6736(77)92585-5 · doi:10.1016/s0140-6736(77)92585-5
- Allgrove, 1977, Cushing's disease: failure of treatment with cyproheptadine, Br Med J, 1, 686, 10.1136/bmj.1.6062.686-a · doi:10.1136/bmj.1.6062.686-a
- D'Ercole, 1977, Treatment of Cushing disease in childhood with cyproheptadine, J Pediatr, 90, 834, 10.1016/S0022-3476(77)81265-1 · doi:10.1016/s0022-3476(77)81265-1
- Kritzler, 1983, Sodium valproate and corticotropin suppression in the child treated for seizures, J Pediatr, 102, 142, 10.1016/S0022-3476(83)80313-8 · doi:10.1016/s0022-3476(83)80313-8
- Koppeschaar, 1982, Sodium valproate and heterogeneity of pituitary dependent Cushing's syndrome, Lancet, 1, 1253, 10.1016/S0140-6736(82)92383-2 · doi:10.1016/s0140-6736(82)92383-2
- Koppeschaar, 1984, Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary, Acta Endocrinol (Copenh), 107, 471, 10.1530/acta.0.1070471 · doi:10.1530/acta.0.1070471
- Cavagnini, 1984, Sodium valproate in Cushing's disease, Lancet, 2, 162, 10.1016/S0140-6736(84)91074-2 · doi:10.1016/s0140-6736(84)91074-2
- Ambrosi, 1983, Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion, J Endocrinol Invest, 6, 305, 10.1007/BF03347595 · doi:10.1007/bf03347595
- Reincke, 1988, The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease, Klin Wochenschr, 66, 686, 10.1007/BF01726927 · doi:10.1007/bf01726927
- Loli, 1984, Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion, J Endocrinol Invest, 7, 93, 10.1007/BF03348396 · doi:10.1007/bf03348396
- Allolio, 1982, Valproate in Cushing's syndrome, Lancet, 1, 171, 10.1016/S0140-6736(82)90422-6 · doi:10.1016/s0140-6736(82)90422-6
- Koppeschaar, 1986, Response to neurotransmitter modulating drugs in patients with Cushing's disease, Clin Endocrinol (Oxf), 25, 661, 10.1111/j.1365-2265.1986.tb03621.x · doi:10.1111/j.1365-2265.1986.tb03621.x
- Beckers, 1990, Cyclical Cushing's disease and its successful control under sodium valproate, J Endocrinol Invest, 13, 923, 10.1007/BF03349657 · doi:10.1007/bf03349657
- Nussey, 1988, The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome, Clin Endocrinol (Oxf), 28, 373, 10.1111/j.1365-2265.1988.tb03668.x · doi:10.1111/j.1365-2265.1988.tb03668.x
- Ferone, 2007, Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas, Eur J Endocrinol, 156, S37, 10.1530/eje.1.02351 · doi:10.1530/eje.1.02351
- Nobels, 2000, Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma, Eur J Endocrinol, 143, 615, 10.1530/eje.0.1430615 · doi:10.1530/eje.0.1430615
- Greenman, 2005, Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth, Clin Endocrinol (Oxf), 63, 39, 10.1111/j.1365-2265.2005.02295.x · doi:10.1111/j.1365-2265.2005.02295.x
- Pirker, 1996, Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT, J Nucl Med, 37, 1931
- Adams, 1981, Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism, Clin Endocrinol (Oxf), 15, 479, 10.1111/j.1365-2265.1981.tb00691.x · doi:10.1111/j.1365-2265.1981.tb00691.x
- Yin, 1994, Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine, FEBS Lett, 339, 73, 10.1016/0014-5793(94)80387-0 · DOI
- Lamberts, 1977, The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy, Clin Endocrinol (Oxf), 7, 185, 10.1111/j.1365-2265.1977.tb01314.x · doi:10.1111/j.1365-2265.1977.tb01314.x
- Adachi, 1996, Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine, Intern Med, 35, 207, 10.2169/internalmedicine.35.207 · doi:10.2169/internalmedicine.35.207
- McNicol, 1986, A study of corticotroph adenomas in Cushing's disease: no evidence of intermediate lobe origin, Clin Endocrinol (Oxf), 24, 715, 10.1111/j.1365-2265.1986.tb01668.x · doi:10.1111/j.1365-2265.1986.tb01668.x
- Meij, 2000, Double pituitary lesions in three patients with Cushing's disease, Pituitary, 3, 159, 10.1023/A:1011499609096 · doi:10.1023/a:1011499609096
- Nielsen, 2001, Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo, J Endocrinol Invest, 24, 430, 10.1007/BF03351043 · doi:10.1007/bf03351043
- Pivonello, 2003, Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors, J Endocrinol Invest, 26, 82
- Invitti, 1991, Effect of sandostatin on CRF-stimulated secretion of ACTH, β-lipotropin and β-endorphin, Horm Metab Res, 23, 233, 10.1055/s-2007-1003660 · doi:10.1055/s-2007-1003660
- Julesz, 1980, Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushing's disease, Endokrinologie, 76, 68
- Kraus, 1999, Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids, FEBS Lett, 459, 200, 10.1016/S0014-5793(99)01236-3 · doi:10.1016/s0014-5793(99)01236-3
- Ruan, 2006, SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?, Mol Endocrinol, 20, 426, 10.1210/me.2005-0283 · DOI
- Lacroix, 2012, Medical treatment of Cushing's disease with pasireotide, Eur J Endocrinol, 8, 99, 10.17925/EE.2012.08.02.99 · doi:10.17925/ee.2012.08.02.99
- Cukier, 2009, Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease, Clin Endocrinol (Oxf), 71, 305, 10.1111/j.1365-2265.2008.03486.x · doi:10.1111/j.1365-2265.2008.03486.x
- Culler, 2011, Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors, Horm Metab Res, 43, 854, 10.1055/s-0031-1287769 · doi:10.1055/s-0031-1287769
- Colao, 2010, Pituitary carcinomas, Front Horm Res, 38, 94, 10.1159/000318499 · doi:10.1159/000318499
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationComplications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Pivonello, R., Fleseriu, M., Newell-Price, J., Bertagna, X., Findling, J., Shimatsu, A., Gu, F., Auchus, R., Leelawattana, R., Lee, E. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30240-0 · Cited by 222
Self-citationClayton, R. N., Jones, P. W., Reulen, R. C., Stewart, P. M., Hassan-Smith, Z. K., Ntali, G., Karavitaki, N., Dekkers, O. M., Pereira, A. M., Bolland, M., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30005-5 · Cited by 208
Metadata
- Authors
- Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2015-08-01
- Volume
- 36
- Issue
- 4
- Pages
- 385-486
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1910274646
- Cited by
- 465
- References
- 641
- FWCI
- 27.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.